Citigroup
INBX

Citigroup’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Citigroup’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-331,302
Closed -$11.6M – 5888
2024
Q1 		$11.6M Buy
331,302
+286,612
+641% +$10.5M 0.01% 1170
2023
Q4 		$1.7M Sell
44,690
-4,554
-9% -$97.6K ﹤0.01% 2382
2023
Q3 		$904K Buy
49,244
+1,611
+3% +$33.7K ﹤0.01% 2599
2023
Q2 		$1.24M Sell
47,633
-76,702
-62% -$1.79M ﹤0.01% 2672
2023
Q1 		$2.35M Buy
124,335
+37,822
+44% +$880K ﹤0.01% 1909
2022
Q4 		$2.13M Sell
86,513
-34,948
-29% -$1.03M ﹤0.01% 1986
2022
Q3 		$2.18M Buy
121,461
+118,361
+3,818% +$2.13M ﹤0.01% 2084
2022
Q2 		$36K Sell
3,100
-13,826
-82% -$203K ﹤0.01% 4692
2022
Q1 		$377K Sell
16,926
-20,179
-54% -$515K ﹤0.01% 3693
2021
Q4 		$1.62M Buy
37,105
+33,723
+997% +$1.35M ﹤0.01% 2795
2021
Q3 		$113K Buy
3,382
+1,879
+125% +$57.2K ﹤0.01% 4375
2021
Q2 		$41K Buy
1,503
+866
+136% +$18K ﹤0.01% 4922
2021
Q1 		$13K Sell
637
-995
-61% -$29.1K ﹤0.01% 5520
2020
Q4 		$54K Buy
+1,632
New +$43.4K ﹤0.01% 5989

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup's INBX Position: Q2 2024 in Review

Citigroup sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 331,302 shares — an estimated $11.6M sold.

Citigroup first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $11.6M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Citigroup reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Citigroup sold 331,302 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $11.6M.
  • Citigroup first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Citigroup's Inhibrx, Inc. Common Stock position peaked at $11.6M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.